Liminal Biosciences Q4 EPS $(1.72) Up From $(2.90) YoY, Sales $179.43K Down From $238.00K YoY
Liminal Biosciences (NASDAQ:LMNL) reported quarterly losses of $(1.72) per share. This is a 40.69 percent increase over losses of $(2.90) per share from the same period last year. The company reported $179.43 thousand
